Friday, January 23, 2015
I am often asked about the long term efficacy
J Neural Transm. 2014 May;121(5):521-30. doi: 10.1007/s00702-013-1145-3. Epub 2014 Jan 10.
Schramm A1, Ndayisaba JP, Auf dem Brinke M, Hecht M, Herrmann C, Huber M, Lobsien E, Mehnert S, Reuter I, Stenner A, van der Ven C, Winterholler M,Kupsch A, Wissel J.
No significant differences between disease entities or between upper and lower limb treatment were observed with regard to efficacy and safety following onabotulinumtoxin A treatment.
Minor to moderate side effects were reported in <1 nbsp="" of="" population.="" span="" study="" the="">1>
We conclude that repetitive treatment of focal and multifocal spasticity with onabotulinumtoxin A provides a safe and efficacious therapeutic strategy for patients with different disease entities of the central nervous system.
J Child Neurol. 2014 Feb;29(2):210-3. doi: 10.1177/0883073813495306. Epub 2013 Aug 21.
botulinum toxin A; cerebral palsy; children; hypertonia treatment; outcome